Janus Henderson Group’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,575
Closed -$394K 2813
2022
Q4
$394K Sell
23,575
-23,579
-50% -$398K ﹤0.01% 1837
2022
Q3
$810K Buy
47,154
+16,730
+55% +$263K ﹤0.01% 1744
2022
Q2
$239K Buy
30,424
+153
+0.5% +$1.31K ﹤0.01% 2220
2022
Q1
$335K Buy
30,271
+13,113
+76% +$147K ﹤0.01% 2152
2021
Q4
$302K Buy
+17,158
New +$333K ﹤0.01% 2196
2020
Q3
Sell
-899,415
Closed -$32.7M 1382
2020
Q2
$32.7M Buy
+899,415
New +$25.3M 0.02% 592

Janus Henderson Group's ONEM Position: Q1 2023 in Review

Janus Henderson Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 23,575 shares — an estimated $394K sold.

Janus Henderson Group first reported a position in ONEM in Q2 2020 and held it in 6 quarters. The position peaked at $32.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Janus Henderson Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Janus Henderson Group sold 23,575 1Life Healthcare shares in Q1 2023, an estimated $394K.
  • Janus Henderson Group first reported a position in 1Life Healthcare in Q2 2020 and held it in 6 quarters.
  • Janus Henderson Group's 1Life Healthcare position peaked at $32.7M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.